ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Bioinformatics analysis based on DNA methylation data identified in lung adenocarcinoma subgroups with different immune characteristics and clinical outcomes

Yu, Ruilin; Huang, Xiaoming; Lin, Junqi; Lin, Shaoming; Shen, Guanle; Chen, Wenbiao*南方医科大学; 1
Journal of Thoracic Disease2023-4DOI: 10.21037/jtd-23-494
6阅读
引用收藏
分享

摘要

Background: DNA methylation can be used to predict clinical outcomes and improve the classification of tumors. The present study aimed to develop a new lung adenocarcinoma (LUAD) classification system according to the immune cell gene-related methylation sites and to reveal the survival outcomes, clinical characteristics, immune cell infiltration, stem cell characteristics, and genomic variations of each molecular subgroup. @@@ Methods: The DNA methylation sites of LUAD samples collected from The Cancer Genome Atlas (TCGA) database were analyzed, and the prognosis-related differential methylation sites (DMS) were screened. Consistent clustering of the samples was conducted using ConsensusClusterPlus, and the classification results were verified by principal component analysis (PCA). The survival and clinical results, immune cell infiltration, stemness, DNA mutation, and copy number variation (CNV) of each molecular subgroup were analyzed. @@@ Results: A total of 40 DMS were obtained by difference and univariate COX analyses, and the TCGA LUAD samples were divided into three subgroups: cluster 1 (C1), cluster 2 (C2), and cluster 3 (C3). Among these subgroups, the overall survival (OS) of C3 was significantly higher than that of C1 and C2. Compared with C1 and C3, C2 had the lowest innate immune cell and adaptive immune cell infiltration scores; the lowest stromal score, immune score, and iconic immune checkpoint expression; and the highest expression of index (mDNAsi), and tumor mutational burden (TMB). @@@ Conclusions: In this study, we proposed a LUAD typing system based on DMS, which was closely related to the survival, clinical features, immune characteristics, and genomic variations of LUAD, and may contribute to the development of personalized therapy for new specific subtypes.

学科与关键词

关键词
Lung adenocarcinoma (LUAD)DNA methylationmolecular subgroupsimmune cell infiltrationgenomic variation
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Thoracic Disease
发表日期
2023-04
卷期
第 15 卷, 第 4 期
页码
2184-+
DOI
10.21037/jtd-23-494
语言
ENGLISH
成果收录
SCIE
资助标注
Scientific Research Projects of Medical and Health Institutions of Longhua District, Shenzhen [2022011, 2022105, 2020096]; Basic and Applied Basic Research Fund of Guangdong Province [2021A1515110967]

作者

  • Y

    Yu, Ruilin (第一作者)

    southern med univ

  • H

    Huang, Xiaoming

    southern med univ

查看全部 6 位作者收起作者
  • L

    Lin, Junqi

    southern med univ

  • L

    Lin, Shaoming

  • S

    Shen, Guanle

  • C

    Chen, Wenbiao (通讯)

    1 · 2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417